The VELETI II Trial (Sealing Moderate Coronary Saphenous Vein Graft Lesions With Paclitaxel-Eluting Stents): Local Mechanical Intervention Fails to Stop Atheroprogression in Saphenous Vein Grafts.
From the Department of Cardiology, Munich University Clinic, Ludwig-Maximilians University, Germany; and DZHK (German Center for Cardiovascular Research), Partner site Munich Heart Alliance, Munich, Germany. julinda.mehilli@med.uni-muenchen.de.
Julinda
J
Mehilli
D017023:Coronary Angiography; D001026:Coronary Artery Bypass; D054855:Drug-Eluting Stents; D006083:Graft Occlusion, Vascular; D006801:Humans; D017239:Paclitaxel; D012501:Saphenous Vein; D015607:Stents; D016896:Treatment Outcome
D017239:Paclitaxel
Editorials; atherosclerosis; coronary artery disease; drug-eluting stents; life expectancy; stent